Vantage Consulting Group Inc FGEN Holdings History
Vantage Consulting Group Inc's FibroGen Inc Holding Summary
As of 2025-03-31, Vantage Consulting Group Inc held 7,828.28 shares of FibroGen Inc(FGEN), totaling $60,650.00. This investment constitutes 1.21% of their stock portfolio, and Vantage Consulting Group Inc now holds 0.19% of the outstanding FibroGen Inc(FGEN) stock.
The initial trade took place in 2020Q4. And since then Vantage Consulting Group Inc has made 1 purchases of FGEN, at an average price of $1,050.86, for a total of 24,250.12 shares. In addition, there have been 3 sales at an average price of $502.06 for 16,421.84 shares. Based on historical transaction data and FGEN's current price of $6.19, Vantage Consulting Group Inc's estimated gain on his FGEN holdings is $-17.19 Mil, reflecting a -67.46% gain to date.
Vantage Consulting Group Inc FGEN ($6.19) Holding Chart
Vantage Consulting Group Inc FGEN ($6.19) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
